Skip to main content

Rho

  • Program Strategy
    • Program Strategy

      We provide comprehensive services to guide you through the development and execution of a program strategy, across all stages of development and life cycle management, for drugs, biologics, and medical devices.

      Overview
      • RhoIcons_Menu_RegulatoryStrategyRegulatory Strategy
      • RhoIcons_Menu_ClinicalDevClinical Development
  • Clinical Trials
    • Clinical Trials

      Through decades of focused therapeutic expertise, strong site and investigator relationships and an insider’s understanding of the regulatory landscape, Rho’s team of experts ensure consistent trials—traditional, virtual, and hybrid—that run smarter and more efficiently.

      • RhoIcons_Menu_NeuroNeurology & Psychiatry
      • RhoIcons_Menu_AnalgesiaAnalgesia
      • RhoIcons_Menu_RareDiseaseRare Disease
      • RhoIcons_Menu_InfectiousDiseaseInfectious Disease & Vaccines
      • RhoIcons_Menu_OtherTherapeuticAdditional Therapeutic Experience
      • FSP for Biotech
      • Federal Programs
  • Marketing Applications
    • Marketing Applications

      Marketing application submissions, including NDAs, BLAs, and MAAs, are the culmination of years of research and the final hurdle before a product makes it to market. Let our integrated team of experts get your product across the finish line.

      Overview
      • RhoIcons_Menu_FDAMeetingsRegulatory Agency Meetings
      • RhoIcons_Menu_IntegratedAnalysisIntegrated Analysis Development
      • RhoIcons_Menu_MarketingAppMarketing Application Development
      • RhoIcons_Menu_SubmisionsSubmissions and Publishing
  • Why Rho
    • Why Rho

      • Our Values
      • Our Leadership
      • Community Involvement
      • Awards
  • Resources
    • Resources

      • Resource Center
      • Webinars
      • Our Blog
      • RhoIcons_Menu_InfectiousDiseaseCOVID-19 Resource Center
      • News
      • Events
      • Press Releases
  • Careers
    • Careers

      • Working at Rho
      • Career Opportunities
      • Recruitment Process
      • Benefits
      • Applicant Notices
  • Contact
  • Submit RFP/RFI
  • Sites/Investigators
  • Project Login
  • Search

News

News

Rho Joins Decentralized Trials Alliance (DTRA)

News

Applied Clinical Trials Features Marina Acosta Enslen’s Thoughts on Covid-19 Forcing Companies to Comply with the New E6 (R2) Guidelines

News

WRAL News: Rho donates $25,000 to Durham Public Schools

News

Drug Discovery News: Adapting to a decentralized model during COVID-19 and beyond

News

Contract Pharma: RhoFED receives contract from BARDA

News

RTP Discover: Rho

News

Contract Pharma: Accelerating R&D Trends

News

Contract Pharma: FDA Response to COVID-19

News

Lessons Learned from Conducting a Trial during a Pandemic

News

Rho: ‘The hurdles are high when you have a drug that the world doesn’t need’

  • 1
  • 2
  • 3
  • 4
  • »
  • Contact
  • Submit RFP/RFI
  • Sites/Investigators
  • Project Login

Program Strategy

  • Overview
  • Regulatory Strategy
  • Clinical Development

Clinical Trials

  • Neurology & Psychiatry
  • Analgesia
  • Rare Disease
  • Infectious Disease & Vaccines
  • Additional Therapeutic Experience
  • FSP for Biotech
  • Federal Programs

Marketing Applications

  • Overview
  • Regulatory Agency Meetings
  • Integrated Analysis Development
  • Marketing Application Development
  • Submissions and Publishing

Why Rho

  • Our Values
  • Our Leadership
  • Community Involvement
  • Awards

Resources

  • Resource Center
  • Webinars
  • Our Blog
  • News
  • Events
  • Press Releases

Careers

  • Working at Rho
  • Career Opportunities
  • Recruitment Process
  • Benefits
  • Applicant Notices

©2021 Rho, Inc. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
rho_symbol